STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹599 Cr | ₹602 Cr | ₹621 Cr | ₹1,210 Cr | ₹966 Cr |
What is the latest Total Non-Current Liabilities ratio of STRIDES PHARMA SCIENCE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹599 Cr |
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹621 Cr |
| Mar2023 | ₹1,210 Cr |
| Mar2022 | ₹966 Cr |
How is Total Non-Current Liabilities of STRIDES PHARMA SCIENCE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹599 Cr | -0.51 | |
| Mar2025 | ₹602 Cr | -3.19 | |
| Mar2024 | ₹621 Cr | -48.65 | |
| Mar2023 | ₹1,210 Cr | 25.33 | |
| Mar2022 | ₹966 Cr | - | |
Compare Total Non-Current Liabilities of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹9,409.5 Cr | 2.7% | -4.9% | 13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | 2.7% |
-4.9% |
13.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses